Arthrocentesis of the Temporomandibular Joint: Systematic Review and Clinical Implications of Research Findings

Aims: To review randomized clinical trials on arthrocentesis for managing temporomandibular disorders (TMD) and to discuss the clinical implications. Methods: On March 10, 2019, a systematic search of relevant articles published over the last 20 years was performed in PubMed, as well as in Scopus, the authors’ personal libraries, and the reference lists of included articles. The focus question was: In patients with TMD (P), does TMJ arthrocentesis (I), compared to any control treatment (C), provide positive outcomes (O)? Results/Conclusion: Thirty papers were included comparing TMJ arthrocentesis to other treatment protocols in patients with disc displacement without reduction and/or closed lock (n = 11), TMJ arthralgia and/or unspecific internal derangements (n = 8), or TMJ osteoarthritis (n = 11). In general, the consistency of the findings was poor because of the heterogenous study designs, and so caution is required when interpreting the meta-analyses. In summary, it can be suggested that TMJ arthrocentesis improves jaw function and reduces pain levels, and the execution of multiple sessions (three to five) is superior to a single session (effect size = 1.82). Comparison studies offer inconsistent findings, with the possible exception of the finding that splints are superior in managing TMJ pain (effect size = 1.36) compared to arthrocentesis, although this conclusion is drawn from very heterogenous studies (I2 = 94%). The additional use of cortisone is not effective for improving outcomes, while hyaluronic acid or platelet-rich plasma positioning may have additional value according to some studies. The type of intervention, the baseline presence of MRI effusion, and the specific Axis I diagnosis do not seem to be important predictors of effectiveness, suggesting that, as in many pain medicine fields, efforts to identify predictors of treatment outcome should focus more on the patient (eg, age, psychosocial impairment) than the disease.

arthrocentesis; disc displacement; osteoarthritis; temporomandibular disorders; temporomandibular joint

1. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: A systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:453–462.

2. Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med 2008;359:2693–2705.

3. Canales GT, Guarda-Nardini L, Rizzatti-Barbosa CM, Conti PCR, Manfredini D. Distribution of depression, somatization and pain related impairment in patients with chronic temporomandibular disorders. J Appl Oral Sci 2019;27:e20180210.

4. Manfredini D, Piccotti F, Ferronato G, Guarda-Nardini L. Age peaks of different RDC/TMD diagnoses in a patient population. J Dent 2010;38:392–399.

5. de Bont LG, Dijkgraaf LC, Stegenga B. Epidemiology and natural progression of articular temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:72–76.

6. Stohler CS, Zarb GA. On the management of temporomandibular disorders: A plea for a low-tech, high prudence therapeutic approach. J Orofac Pain 1999;13:255–261.

7. Al-Belasy FA , Dolwick MF. Arthrocentesis for the treatment of temporomandibular joint closed lock: A review article. Int J Oral Maxillofac Surg 2007;36:773–782.

8. Manfredini D, Piccotti F, Guarda-Nardini L. Hyaluronic acid in the treatment of TMJ disorders : A systematic review of the literature. Cranio 2010;28:166–176.

9. Nitzan DW, Samson B, Better H. Long-term outcome of arthrocentesis for sudden-onset, persistent, severe closed lock of the temporomandibular joint. J Oral Maxillofac Surg 1997;55:151–157.

10. Nitzan DW, Dolwick FM, Martinez GA. Temporomandibular joint arthrocentesis: A simplified treatment for severe, limited mouth opening. J Oral Maxillofac Surg 1991;49:1163–1167.

11. Guarda-Nardini L, Manfredini D, Ferronato G. Arthrocentesis of the temporomandibular joint: A proposal for a single needle technique. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:483–486.

12. Nitzan DW, Etsion I. Adhesive force: The underlying cause of the disc anchorage to the fossa and/or eminence in the temporomandibular joint A new concept. Int J Oral Maxillofac Surg 2002;31:94–99.

13. Nitzan DW, Kreiner B, Zeltser B. TMJ lubrification system: Its effect on the joint function, dysfunction, and treatment approach. Compend Contin Educ Dent 2004;25:437–438.

14. Guarda-Nardini L, Tito R, Staffieri A, Beltrame A. Treatment of patients with arthrosis of the temporomandibular joint by infiltration of sodium hyaluronate: A preliminary study. Eur Arch Otorhinolaryngol 2002;259:279–284.

15. Altman RD. Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin Arthritis Rheum 2000;30(2 suppl):s11–s18.

16. Guarda-Nardini L, Stifano M, Brombin C, Salmaso L, Manfredini D. A one year case series of arthrocentesis with hyaluronic acid injections for temporomandibular joint osteoarthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e14–e22.

17. Manfredini D, Bonnini S, Arboretti R, Guarda-Nardini L. Temporomandibular joint osteoarthritis: An open label trial of 76 patients treated with arthrocentesis plus hyaluronic acid injections. Int J Oral Maxillofac Surg 2009;38:827–834.

18. Davoudi A, Khaki H, Mohammadi I, et al. Is arthrocentesis of temporomandibular joint with corticosteroids beneficial? A systematic review. Med Oral Patol Oral Cir Bucal 2018;23:e367–e375.

19. Bousnaki M, Bakopolou A, Koidis P. Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: A systematic review. Int J Oral Maxillofac Surg 2018;47:188–198.

20. Guarda-Nardini L, Trojan D, Paolin A, Manfredini D. Management of temporomandibular joint degenerative disorders with human amniotic membrane: Hypothesis of action. Med Hypotheses 2017;104:68–71.

21. de Souza RF, Lovato da Silva CH, Nasser M, Fedorowicz Z, Al- Muharraqi MA. Interventions for the management of temporomandibular joint osteoarthritis. Cochrane Database Syst Rev 2012;2012(4):CD007261.

22. Lin Song Y, Yap AU. Outcomes of therapeutic TMD interventions on oral health related quality of life: A qualitative systematic review. Quintessence Int 2018;49:487–496.

23. Nagori SA, Jose A, Roy Chowdhury SK, Roychoudhury A. Is splint therapy required after arthrocentesis to improve outcome in the management of temporomandibular joint disorders? A systematic review and meta analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:97–105.

24. Al-Moraissi EA. Arthroscopy versus arthrocentesis in the management of intrenal derangement of the temporomandibular joint: A systematic review and meta-analysis. Int J Oral Maxillofac Surg 2015;44:104–112.

25. Al Belasy FA, Dolwick MF. Arthrocentesis for the treatment of temporomandibular joint closed lock: A review article. Int J Oral Maxillofac Surg 2007;36:773–782.

26. Manfredini D, Greene CS, Ahlberg J, De Laat A, Lobbezoo F, Klasser GD. Evidence-based dentistry or meta analysis illness? A commentary on current publishing trends in the field of temporomandibular disorders and bruxism. J Oral Rehabil 2019;46:1–4.

27. Yapici-Yavuz G, SimSek-Kaya G, Og˘ul H. A comparison of the effects of methylprednisolone acetate, sodium hyaluronate and tenoxicam in the treatment of non reducing disc displacement of the temporomandibular joint. Med Oral Patol Oral Cir Bucal 2018;23:e351–e358.

28. Grossman E, Vargas Pasqual GV, Poluha RL, Iwaki LCV, Iwaki Filho L, Setogutti ÊT. Single needle arthrocentesis with upper compartment distension versus conventional two-needle arthrocentesis: Randomized controlled clinical trial. Pain Res Manag 2017;2017:2435263.

29. Tatli U, Benlidayi ME, Ekren O, Salimov F. Comparison of the effectiveness of three different treatment methods for temporomandibular joint disc displacement without reduction. Int J Oral Maxillofac Surg 2017;46:603–609.

30. S¸entürk MF, Tüzüner-Öncül AM, Cambazog˘lu M. Prospective short term comparison of outcomes after single or double puncture arthrocentesis of the temporomandibular joint. Br J Oral Maxillofac Surg 2016;54:26–29.

31. Baker Z, Eriksson L, Englesson Sahlström L, Ekberg E. Questionable effect of lavage for treatment of painful jaw movements at disc displacement without reduction: A 3-year randomised controlled follow-up. J Oral Rehabil 2015;42:742–750.

32. Ghanem WA. Arthrocentesis and stabilizing are the treatment of choice for acute intermittent closed lock in patients with bruxism. J Craniomaxillofac Surg 2011;39:256–260.

33. Aktas I, Yalcin S, Sencer S. Prognostic indicators of the outcome of arthrocentesis with and without sodium hyaluronate injection for the treatment of disc displacement without reduction: A magnetic resonance imaging study. Int J Oral Maxillofac Surg 2010;39:1080–1085.

34. Diraçog˘lu D, Saral IB, Keklik B, et al. Arthrocentesis versus nonsurgical methods in the treatment of temporomandibular disc displacement without reduction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:3–8.

35. Alpaslan C, Kahraman S, Güner B, Cula S. Does the use of soft or hard splints affect the short term outcome of temporomandibular joint arthrocentesis? Int J Oral Maxillofac Surg 2008;37:424–427.

36. Sanromán JF. Closed lock (MRI fixed disc): A comparison of arthrocentesis and arthroscopy. Int J Oral Maxillofac Surg 2004;33:344–348.

37. Alpaslan GH, Alpaslan C. Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. J Oral Maxillofac Surg 2001;59:613–618.

38. Ozdamar SM, Alev B, Yarat A. The impact of arthrocentesis with and without hyaluronic acid injection in the prognosis and synovial fluid myeloperoxidase levels of patients with painful symptomatic internal derangement of temporomandibular joint: A randomised controlled clinical trial. J Oral Rehabil 2017;44:73–80.

39. Bouloux GF, Chou J, Krishnan D, et al. Is hyaluronic acid or corticosteroid superior to lactated ringer solution in the short term for improving function and quality of life after arthrocentesis? Part 2. J Oral Maxillofac Surg 2017;75:63–72.

40. Hosgor H, Bas B, Celenk C. A comparison of the outcomes of four minimally invasive treatment methods for anterior disc displacement of the temporomandibular joint. Int J Oral Maxillofac Surg 2017;46:1403–1410.

41. Patel P, Idrees F, Newaskar V, Agrawal D. Sodium hyaluronate: An effective adjunct in temporomandibular joint arthrocentesis. Oral Maxillofac Surg 2016;20:405–410.

42. Hancı M, Karamese M, Tosun Z, Aktan TM, Duman S, Savaci N. Intra-articular platelet rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. J Craniomaxillofac Surg 2015;43:162–166.

43. Tabrizi R, Karagah T, Arabion H, Soleimanpour MR, Soleimanpour M. Outcomes of arthrocentesis for the treatment of internal derangement pain: With or without corticosteroids? J Craniofac Surg 2014;25:e571–e575.

44. Vos LM, Huddleston Slater JJ, Stegenga B. Arthrocentesis as initial treatment for temporomandibular joint arthropathy: A randomized controlled trial. J Craniomaxillofac Surg 2014;42:e134–e139.

45. Huddleston Slater JJ, Vos LM, Stroy LP, Stegenga B. Randomized trial on the effectiveness of dexamethasone in TMJ arthrocentesis. J Dent Res 2012;91:173–178.

46. Bergstrand S, Ingstad HK, Møystad A, Bjørnland T. Long-term effectiveness of arthrocentesis with and without hyaluronic acid injection for treatment of temporomandibular joint osteoarthritis. J Oral Sci 2019;61:82–88.

47. Cömert Kiliç S, Güngörmüs M. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint osteoarthritis: A randomized clinical trial. Int J Oral Maxillofac Surg 2016;45:1538–1544.

48. Cömert Kiliç S. Does injection of corticosteroid after arthrocentesis improve outcomes of temporomandibular joint osteoarthritis? A randomized clinical trial. J Oral Maxillofac Surg 2016;74:2151–2158.

49. Cömert Kiliç S, Güngörmüs M, Sümbüllü MA. Is arthrocentesis plus platelet rich plasma superior to arthrocentesis alone in the treatment of temporomandibular joint osteoarthritis? A randomized clinical trial. J Oral Maxillofac Surg 2015;73:1473–1483.

50. Guarda-Nardini L, Rossi A, Arboretti R, Bonnini S, Stellini E, Manfredini D. Single or multiple session viscosupplementation protocols for temporomandibular joint degenerative disorders: Arandomized clinical trial. J Oral Rehabil 2015;42:521–528.

51. Guarda-Nardini L, Rossi A, Ramonda R, Punzi L, Ferronato G, Manfredini D. Effectiveness of treatment with viscosupplementation in temporomandibular joints with or without effusion. Int J Oral Maxillofac Surg 2014;43:1218–1223.

52. Guarda-Nardini L, Cadorin C, Frizziero A, Ferronato G, Manfredini D. Comparison of 2 hyaluronic acid drugs for the treatment of temporomandibular joint osteoarthritis. J Oral Maxillofac Surg 2012;70:2522–2530.

53. Guarda-Nardini L, Ferronato G, Manfredini D. Two-needle vs single needle technique for TMJ arthrocentesis plus hyaluronic acid injections: A comparative trial over a six month follow up. Int J Oral Maxillofac Surg 2012;41:506–513.

54. Manfredini D, Rancitelli D, Ferronato G, Guarda-Nardini L. Arthrocentesis with or without additional drugs in temporomandibular joint inflammatory degenerative disease: Comparison of six treatment protocols*. J Oral Rehabil 2012;39:245–251.

55. Guarda-Nardini L, Olivo M, Ferronato G, Salmaso L, Bonnini S, Manfredini D. Treatment effectiveness of arthrocentesis plus hyaluronic acid injections in different age groups of patients with temporomandibular joint osteoarthritis. J Oral Maxillofac Surg 2012;70:2048–2056.

56. Guarda-Nardini L, Masiero S, Marioni G. Conservative treatment of temporomandibular joint osteoarthrosis: Intra articular injection of sodium hyaluronate. J Oral Rehabil 2005;32:729–734.

57. Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med 2016;21:125–127.

58. Onishi M. Arthroscopy of temporomandibular joint. Kokubyo Gakkai Zasshi 1975;42:207–213.

59. Greene CS, Laskin DM. Long-term evaluation of conservative treatment for myofascial pain dysfunction syndrome. J Am Dent Assoc 1974;89:1365–1368.

60. Dolwick MF, Dimitroulis G. A re-evaluation of the importance of disc position in temporomandibular disorders. Aust Dent J 1996;41:184–187.

61. Goudot P, Jaquinet AR, Hugonnet S, Haefliger W, Richter M. Improvement of pain and function after arthroscopy and arthrocentesis of the temporomandibular joint: A comparative study. J Craniomaxillofac Surg 2000;28:39–43.

62. de Leeuw R, Boering G, Stegenga B, de Bont LG. Clinical signs of TMJ osteoarthrosis and internal derangement 30 years after nonsurgical treatment. J Orofac Pain 1994;8:18–24.

63. Ohrbach R, Dworkin SF. Five-year outcomes in TMD: Relationship of changes in pain to changes in physical and psychological variables. Pain 1998;74:315–326.

64. Kamisaka M, Yatani H, Kuboki T, Matsuka Y, Minakuchi H. Fouryear longitudinal course of TMD symptoms in an adult population and the estimation of risk factors in relation to symptoms. J Orofac Pain 2000;14:224–232.

65. Manfredini D, Favero L, Gregorini G, Cocilovo F, Guarda- Nardini L. Natural course of temporomandibular disorders with low pain-related impairment: A 2-to-3-year follow up study. J Oral Rehabil 2013;40:436–442.

66. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized controlled trial. J Rheumatol 1998;25:2203–2212.

67. Kolarz G, Kotz R, Hochmayer I. Long-term benefits and repeated treatment cycles of intra articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003;32:310–319.

68. Guarda-Nardini L, Cadorin C, Frizziero A, Masiero S, Manfredini D. Interrelationship between temporomandibular joint osteoarthritis (OA) and cervical spine pain: Effects of intra-articular injection with hyaluronic acid. Cranio 2017;35:276–282.

69. Guarda-Nardini L, Ferronato G, Favero L, Manfredini D. Predictive factors of hyaluronic acid injections short term effectiveness for TMJ degenerative joint disease. J Oral Rehabil 2011;38:315–320.

70. Manfredini D, Favero L, Del Giudice A, Masiero S, Stellini E, Guarda Nardini L. Axis II psychosocial findings predict effectiveness of TMJ hyaluronic acid injections. Int J Oral Maxillofac Surg 2013;42:364–368.

71. Kotiranta U, Suvinen T, Kauko T. Subtyping patients with temporomandibular disorders in a primary health care setting on the basis of the research diagnostic criteria for temporomandibular disorders axis II pain-related disability: A step toward tailored treatment planning? J Oral Facial Pain Headache 2015;29:126–134.

72. Dworkin SF, Huggins KH, Wilson L, et al. A randomized clinical trial using research diagnostic criteria for temporomandibular disorders-axis II to target clinic cases for a tailored self-care TMD treatment program. J Orofac Pain 2002;16:48–63.

73. Vos LM, Stegenga B, Stant AD, Quik EH, Huddleston Slater JJ. Cost effectiveness of arthrocentesis compared to conservative therapy for arthralgia of the temporomandibular joint: A randomized controlled rrial. J Oral Facial Pain Headache 2018;32:198–207.